Abstracts should be submitted by August 29, 2014 through either:
1) Online submission (IDDA website is under construction and will be announced upon completion.)
2) Email submission to: iddchina@126.com
Abstracts should be no more than 300 words in Chinese or 500 words in English. Chinese abstracts should use Song type letters, font size 5. English abstracts should use size 10 Arial.
Contents of the Papers: Topics in the inhaled drug and nasal drug areas, including scientific research, applicable technology, regulation, product development, traditional Chinese medicine (TCM) inhalation studies, clinical trials, clinical application, market research, patient education, and treatment management, PK /PD study, container closure system compatibility, in vivo and in vitro studies, etc..
